$MLPT · MapLight Therapeutics, Inc.

Neuropsychiatric disorder drug developer

Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.

Beyond 13F — activists, insiders, politicians & research

Filed	Insider	Role	Shares	Value
2026-08-18	Catalyst4, Inc.	10%-owner	4,400,000	$50,072,000	Form 4
2026-07-30	Catalyst4, Inc.	10%-owner	1,209,225	$15,314,794	Form 4

from2028 — cross-site stock view. Rebuilt at publish time.